Benzinga | Nov 15, 2021 10:56AM EST

Roivant Sciences Q2 EPS $(0.32) Misses $(0.15) Estimate, Sales $13.99M Beat $6.94M Estimate

Roivant Sciences (NASDAQ:ROIV) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.15) by 113.33 percent. The company reported quarterly sales of $13.99 million which beat the analyst consensus estimate of $6.94 million by 101.54 percent.